Nurith Aizenman
[Copyright 2024 NPR]
-
South Africa is a case study of the inequities around the coronavirus vaccine. It has one of the world's worst outbreaks, fueled by a new variant. Yet officials are struggling to buy enough vaccines.
-
New results from a COVID-19 vaccine trial in South Africa suggest the vaccine that was developed by AstraZeneca may not be as effective against the variant found there.
-
Not everyone gets tested. A new model estimates how many infections are missed because of this and how many people are actively shedding the virus. The results lend urgency to the vaccine race.
-
New research shows how official figures understate the U.S. pandemic: On any given day the number of infected people who are actively contagious is ten times that day's tally of new reported cases.
-
Six takeaways from discussions at the annual meeting of the World Health Organization's Executive Board. -
A year ago today, the WHO first learned of a cluster of pneumonia cases in Wuhan, China of "unknown" origin. Here's the impact of that fateful day, by the numbers. -
A new study suggests big sisters have a powerful impact. (Sorry, big brothers, you don't make as much of a difference.) But there are also potential downsides for the sisters.
-
A new study suggests kids in poor countries benefit hugely from having older sisters — who are more likely than brothers or even mothers — to engage in stimulating play.
-
It's part of an ongoing back-and-forth: Republican presidents ban U.S. funds for foreign aid groups that 'promote' abortion, Democratic presidents revoke the ban. This time things could be different. -
Steve Davis lays out the reasons for his (relatively) rosy outlook In his new book: Undercurrents: Channeling Outrage to Spark Practical Activism.
